<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Delphian lymph node":1,
"lateral lymph node":1,
"papillary thyroid cancer":21,
"Thyroid cancer":76,
"lymph node classification":1,
"nodal metastasis":1,
"preoperative radiography":1,
"BRAF":7,
"PIK3CA":2,
"Papillary thyroid carcinoma":43,
"RET":3,
"Diameter":1,
"Prognosis":14,
"Recurrence":7,
"Volume":2,
"Breast cancer":19,
"Core needle biopsy":2,
"HER2":1,
"Hormone receptor":1,
"Ki-67":2,
"Molecular markers":2,
"guidelines":1,
"incidence rate":1,
"Cancer registry":2,
"China":3,
"Neoplasms":6,
"Population-based study":2,
"Survival rate":2,
"breast neoplasms":4,
"epidemiology":7,
"hepatitis B infection":1,
"hepatitis B surface antigens":1,
"pathology":6,
"Neuromonitoring":1,
"Recurrent laryngeal nerve":2,
"Surgery":7,
"Thyroid":32,
"Voice":2,
"Endoscopic thyroidectomy":3,
"Three-dimensional endoscopy":1,
"Achaete-scute homolog like 1":1,
"Carcinoma de célula pequeña":1,
"Cáncer de próstata":1,
"Diferenciación neuroendocrina":1,
"Factor de transcripción clase III/IV POU3F2":1,
"Factores de transcripición de desarrollo neural":1,
"Neural development transcription factors":1,
"Neuroendocrine differentiation":1,
"Prostate cancer":3,
"Small-cell carcinoma":1,
"Transcription factor class III/IV POU3F2":1,
"Competitive risk model":1,
"Peripheral dose":1,
"Risk assessment":2,
"Second primary cancer":3,
"Non-Hodgkin lymphoma":1,
"Renal cancer":1,
"Second cancer":1,
"Second malignant neoplasm":1,
"Meta-analysis":7,
"Open":1,
"Recurrence rate":1,
"Robotic":1,
"Thyroidectomy":20,
"18F-TFB":1,
"PET/CT":3,
"thyroid imaging":1,
"Melanoma":2,
"POT1":1,
"Telomere":1,
"dosimetry":2,
"radioactive iodine":5,
"therapy":1,
"Cervical Lymph Node Metastasis":2,
"Extrathyroidal Extension":3,
"Medullary Thyroid":1,
"Medullary Thyroid Carcinoma":7,
"calcification":3,
"egg shell":1,
"ring":1,
"thymoma":1,
"TgAb":2,
"differentiated thyroid carcinoma":7,
"high sensitive":1,
"outcome":2,
"thyroglobulin":9,
"Body fat ratio":1,
"Obesity":1,
"Roux-en-Y gastric bypass":1,
"Thyroid hormone":4,
"Thyroid tumors":1,
"Benign Thyroid Nodule":6,
"Bipolar Group":1,
"Percutaneous Ethanol Injection Therapy":1,
"Radio Frequency Ablation":1,
"Thyroid Nodule":20,
"K-TIRADS":1,
"Thyroid cancer, follicular":1,
"Ultrasonography":11,
"Mucoepidermoid carcinoma":1,
"Radioactive iodine treatment":1,
"Salivary gland carcinoma":1,
"Secondary carcinoma":1,
"RAS":2,
"EIF1AX":1,
"Familial nonmedullary thyroid carcinoma":1,
"TERT promoter mutations":2,
"Aged":1,
"Papillary thyroid microcarcinoma":5,
"Thyroid cancer, papillary":2,
"Treatment outcomes":1,
"Hyperthyroidism":2,
"Hypothyroidism":6,
"Acromegaly":1,
"IPMN":1,
"Pancreatic cysts":1,
"anaplastic thyroid carcinoma":5,
"atypical adenoma":1,
"epithelial-mesenchymal transition":2,
"frequency domain analysis":1,
"head and neck ultrasound":2,
"photoacoustic imaging":2,
"tissue characterization":1,
"RET protooncogene":1,
"multiple endocrine neoplasia type 2":2,
"phaeochromocytoma":1,
"Neoplasm staging":1,
"Thyroid neoplasms":24,
"Basal subtype":1,
"Metastatic cancer":1,
"Primary cancer":1,
"Radioresistance":1,
"McGill Thyroid Nodule Score":1,
"fine-needle aspiration biopsy":1,
"pediatric":4,
"thyroid nodules":13,
"thyroid ultrasound":2,
"well-differentiated thyroid carcinoma":1,
"Chernobyl nuclear accident":1,
"cohort studies":1,
"cross-sectional studies":1,
"radiation":3,
"BRCA1":1,
"BRCA2":1,
"Microfluidic PCR":1,
"Mutation":1,
"Next-generation sequencing":2,
"anti-thyroglobulin antibodies":1,
"interference":1,
"Endoscopic skull base":1,
"Lung cancer":2,
"Pituitary adenoma":2,
"Pituitary metastasis":1,
"Staging":1,
"Octamethylcyclotetrasiloxane":1,
"Oncogenicity":1,
"Siloxane":1,
"Biokinetics":1,
"Effective half-time":1,
"I-131":1,
"Retention rate":1,
"TSH stimulation":1,
"rhTSH":2,
"FVPTC":1,
"NIFTP":3,
"expression profile":1,
"nanoString":1,
"thyroid neoplasm":2,
"Radioiodine therapy":2,
"Recombinant human thyrotropin":1,
"Therapeutic response":1,
"Autophagy":2,
"EGFR":3,
"Gefitinib-resistance":1,
"HSP90":2,
"Honokiol":1,
"FNA":1,
"cytopathologist":1,
"ultrasound":19,
"Carcinoid tumor":1,
"Incidental":1,
"Intradural":1,
"Primary":1,
"Bethesda classification":1,
"atypia of undetermined significance":1,
"fine needle aspiration":5,
"follicular lesion of undetermined significance":1,
"ERK1/2 pathway":1,
"IL-17B":1,
"IL-17RB":1,
"Invasion":13,
"Metastasis":17,
"CT":1,
"imaging protocol":1,
"radiation dose reduction":1,
"radiation shielding":1,
"Bethesda":5,
"diagnostic value":3,
"fine needle aspiration biopsy":3,
"pre-Bethesda":1,
"histology":3,
"population study":1,
"size":1,
"variants":2,
"predictive genetic testing":1,
"lymph node metastasis":8,
"male":2,
"young age":1,
"miR-10a-5p":1,
"MicroRNA":4,
"renal cell carcinoma":3,
"spindle and kinetochore-associated protein 1":1,
"tyrosine kinase inhibitor resistance":1,
"D631Y mutation":1,
"medullary thyroid cancer":9,
"pheochromocytoma":1,
"Radiotherapy":5,
"external beam radiation":1,
"head and neck cancer":5,
"Neck Dissection":7,
"Epidemiologic studies":1,
"Health surveys":1,
"Registries":2,
"Reproducibility of results":1,
"Self report":1,
"Sensitivity and specificity":1,
"Cancer":21,
"Conditional survival":1,
"Population-based":2,
"Relative survival":1,
"SEER":3,
"BDE-209":1,
"BRAF V600E":3,
"Flame retardant chemicals":1,
"Tris(2-chloroethyl) phosphate (TCEP)":1,
"core-needle biopsy":2,
"fine-needle aspiration":13,
"malignancy rate":1,
"18F-FDG PET/CT":1,
"propensity score analysis":1,
"thyroid incidentalomas":1,
"FDG-PET/CT":1,
"TIRADS":1,
"follow-up":3,
"suspicious thyroid nodules":1,
"Japan":2,
"Pediatric papillary thyroid carcinoma":1,
"Sporadic thyroid cancer":1,
"Ukraine":1,
"Beta-catenin":1,
"Desmoid-type fibromatosis":1,
"Nodular fasciitis":1,
"Papillary carcinoma":4,
"Adult":3,
"Age distribution":1,
"Incidence":6,
"Mortality/trends":1,
"Neoplasms/epidemiology":1,
"Sex distribution":1,
"Sex factors":1,
"Time factors":1,
"Gender inequality":1,
"nuclear atypia":1,
"thyroid cytology":2,
"comprehensive lateral neck dissection":1,
"lateral neck dissection":1,
"persistent thyroid cancer":1,
"recurrent thyroid cancer":2,
"salvage neck dissection":1,
"well-differentiated thyroid cancer":3,
"General anesthesia":1,
"Local anesthesia":1,
"Monitored anesthesia care":1,
"Differentiated thyroid cancer":8,
"Dynamic risk stratification":3,
"cost analysis":2,
"molecular testing":4,
"CCL27":1,
"CCR10":1,
"ERK1/2":1,
"Migration":6,
"NIFTPs":1,
"follicular-patterned thyroid lesions":1,
"miRNAs":1,
"aspiration":1,
"diagnostic adequacy rate":1,
"fine-needle cytology":1,
"nonaspiration":1,
"suspicious lymph node":1,
"Hypercalcemia":1,
"Hyperparathyroidism":2,
"Hypocalcemia":1,
"Hypoparathyroidism":1,
"Angiogenesis":2,
"Bcl-2":1,
"Notch1":1,
"Thyroid carcinoma":24,
"VEGF":2,
"miR-34b":1,
"Gastric neoplasms":1,
"Population register":1,
"Second primary neoplasm":1,
"lower-risk thyroid cancer":1,
"outcomes":4,
"regional variation":1,
"treatments":1,
"Lymph nodes":3,
"mortality":7,
"neoplasm metastasis":2,
"Age":1,
"Descriptive epidemiology":1,
"Functional outcome":1,
"Nationwide study":1,
"Reconstruction":1,
"Sex":1,
"Trachea":1,
"Tracheostomy":1,
"GABRB2":1,
"Oncogene":1,
"Akt":2,
"MDM2":1,
"Proliferation":12,
"RasGRP3":1,
"Immunohistochemistry":9,
"Radioiodine":6,
"Thyroid autoimmunity":1,
"Lead":1,
"nodular goiter":2,
"thyroid adenoma":1,
"thyroid hormones":3,
"Carcinoma tiroides":1,
"Ganglio centinela":1,
"Metástasis ganglionar":1,
"Sentinel lymph node":1,
"conflicts of interest":1,
"ethics":1,
"overdiagnosis":2,
"public health":2,
"shared decision-making":1,
"treatment":4,
"NCoR":1,
"myeloid cell":1,
"premetastatic niche":1,
"retinoid X receptor":1,
"LKB1":1,
"YAP/TAZ":1,
"histone methylation":1,
"serine biosynthesis":1,
"E3 Ligase UBE4":1,
"Poly r(C) binding protein (PCBP) 1":1,
"Cancer du larynx":1,
"Cancer of the larynx":1,
"Carotid invasion":1,
"Envahissement carotide":1,
"Recurrent tumor":1,
"Récidive tumorale":1,
"Formalin-fixed":1,
"Paraffin-embedded":1,
"Tissue microarray":1,
"Tumorigenesis":3,
"cMYC":1,
"Chronic lymphocytic thyroiditis":1,
"PD-1":1,
"PD-L1":1,
"Tumor-infiltrating lymphocytes":1,
"biomarkers":3,
"cytology":5,
"diagnostic imaging":1,
"differential diagnosis":1,
"oncogenes":1,
"18":1,
"F-FDG":1,
"F-fluorodeoxyglucose":1,
"PET PET/CT":1,
"Thyroid incidentaloma":1,
"positron emission tomography":1,
"Bax":1,
"Bcl2":1,
"NVP-AUY922":1,
"dipeptidyl peptidase-IV inhibitor":1,
"gemigliptin":1,
"synergism":2,
"sphingosine kinase 1":1,
"GO ontology":1,
"KEGG pathways":1,
"differentially expressed genes":1,
"protein–protein interaction network":1,
"Decision-making":1,
"Diagnosis":9,
"Galectin-1":1,
"Peptides":1,
"Phage display":1,
"Ultrasmall superparamagnetic particles of iron oxide":1,
"Gastrinoma":1,
"Neuroendocrine tumours":1,
"Somatostatin":3,
"Somatostatin analogues":2,
"Environment temperature":1,
"cancer incidence rate":1,
"statistical analysis":1,
"high-mobility group A2":1,
"let-7b":1,
"microRNAs":1,
"Gefitinib":1,
"Vemurafenib":1,
"RET/PTC":1,
"TERT":2,
"distant metastasis":2,
"Case report":3,
"Cinacalcet":2,
"Ectopic calcification":1,
"Hemodialysis":1,
"Parathyroid carcinoma":3,
"Secondary hyperparathyroidism":1,
"Carcinoma, papillary":4,
"Intermuscular lymph node":1,
"Lymphoma":3,
"Radioiodine ablation":1,
"Growth suppression":1,
"PTEN":3,
"RBM38":1,
"mRNA stability":1,
"CXCL5":1,
"PDL1":1,
"drug resistance":1,
"p-eIF2α":1,
"triple-negative breast cancer":3,
"vascular endothelial growth factor":2,
"Deoxyglucose":1,
"Hypermetabolic thyroid nodules":1,
"Tomography, X-ray computed":1,
"Tomography, emission-computed":1,
"Fiducial markers":1,
"Neoplasm recurrence, local":1,
"Austria":1,
"Cohort study":2,
"Relative risk":1,
"Retrospective":1,
"Completion surgery":1,
"Lymph node dissection":2,
"gynecological cancer":1,
"oncology":5,
"Central lymph node metastasis":2,
"Lateral lymph node metastasis":1,
"Risk factors":3,
"Skip metastasis":1,
"General Practice / Family Medicine":1,
"Thyroid Disease":2,
"MRI outcomes":1,
"NEDA":1,
"alemtuzumab":1,
"annualized relapse rate":1,
"autoimmune event":1,
"infusion-associated reaction":1,
"multiple sclerosis":1,
"no evidence of disease activity":1,
"risk mitigation":1,
"HIF-1α/ HIF-2α/ vitamin C/GLUT1/ thyroid cancer":1,
"AP-2α":1,
"Cholangiocarcinoma":1,
"EMT":2,
"MAPK7":1,
"TGF-β":1,
"miR-200b":1,
"adiposity":1,
"children":4,
"iodine":2,
"thyroid nodule(s)":1,
"proline rich 11":1,
"tongue squamous cell carcinoma":1,
"Imaging":1,
"Radiotracers":1,
"tuberous sclerosis":1,
"Causative variant":1,
"Gene panel":1,
"Hereditary breast cancer":1,
"NGS":2,
"MALAT1":3,
"MiR-21":1,
"siRNA":2,
"Fine needle aspiration cytology":2,
"pitfalls":1,
"2017":2,
"Alkaline phosphatase":1,
"Bisphosphonates":1,
"Bone pain":1,
"CT scan":1,
"Calcium (serum)":1,
"Calcium carbonate":1,
"Capecitabine":1,
"Endocrine-related cancer":1,
"Fatigue":1,
"Female":3,
"Fluid repletion":1,
"Fluorouracil":1,
"Furosemide":1,
"Greece":1,
"Histopathology":2,
"Hypercalcaemia":1,
"Hypophosphataemia":1,
"Lymphadenectomy":1,
"MRI":2,
"Metastatic carcinoma":1,
"Myasthaenia":1,
"October":1,
"PTH":1,
"Pamidronate":1,
"Parathyroid":1,
"Parathyroid hormone":1,
"Parathyroidectomy":3,
"Phosphate (serum)":1,
"Polydipsia":1,
"Polyuria":1,
"Radionuclide imaging":1,
"Sestamibi scan":1,
"Temozolomide":1,
"Ultrasound scan":1,
"Unique/unexpected symptoms or presentations of a disease":1,
"White":2,
"Zoledronic acid":2,
"cyclin-dependent kinase 8 (CDK8)":1,
"miR-148a":1,
"papillary thyroid carcinoma (PTC)":2,
"TSH":1,
"gonadal hormones":1,
"thyroid-stimulating hormone repressive therapy":1,
"Stage thyroidectomy":1,
"bilateral injury":1,
"intraoperative neuromonitoring (IONM)":1,
"recurrent laryngeal nerve (RLN)":1,
"thyroid surgery":4,
"complications":1,
"tracheal resection":1,
"neoplasm recurrence":1,
"skin":1,
"Thoracic duct":1,
"single port":1,
"thoracoscopic approach":1,
"familial adenomatous polyposis (FAP)":1,
"genetic testing":1,
"hereditary nonpolyposis colorectal cancer (HNPCC)":1,
"multiple endocrine neoplasms":1,
"cartilages of larynx":1,
"larynx stenosis":1,
"open partial laryngectomy":1,
"piezoelectric knife":1,
"MAP kinase signaling system":1,
"cancer stem cells":2,
"phosphortidylinositol-3 kinase":1,
"sonic hedgehog":1,
"Clinicopathologic characteristics":1,
"Hashimoto’s thyroiditis":1,
"Blurred or/and partially missing boundaries":1,
"Compact shapes":1,
"Isoperimetric constraint":1,
"Lesion segmentation":1,
"Level set":1,
"BRAF mutation":5,
"UNC5D":1,
"tumor-suppressive function":1,
"BRAFV600E mutation":2,
"efficacy":1,
"radioiodine remnant ablation":2,
"PSM":1,
"T2DM":1,
"TC":1,
"overall survival":5,
"TP53":2,
"breast invasive carcinoma":1,
"driver mutation":1,
"insular thyroid carcinoma":1,
"propensity score matching":1,
"lobular carcinoma in situ":1,
"lumpectomy":1,
"mastectomy":1,
"Anaplastic transformation":1,
"Long-term survival":1,
"Pulmonary metastasis":1,
"Cytokeratin":1,
"isolated skeletal muscle metastasis":1,
"nonsmall cell lung carcinoma":1,
"parathyroid hormone-related peptide":1,
"progression-free survival":2,
"superior vena cava":1,
"thyroid transcription factor":1,
"Follicular thyroid carcinoma":4,
"histopathological types":1,
"anterior chest wall":1,
"cirrhosis":1,
"hepatitis C virus":1,
"hepatocellular carcinoma":5,
"Blood Coagulation Factors":1,
"Fibrinolysis":1,
"Receptor, Thyroid Hormone":1,
"Venous Thromboembolism":2,
"gas chromatography-time-of-flight mass spectrometry":1,
"laryngeal squamous cell carcinoma":1,
"metabolomics":4,
"ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry":1,
"Decision-making experience":1,
"Decision-making preference":1,
"Psychological distress":1,
"ABCB1":1,
"FTH1P3":1,
"miR-206":1,
"paclitaxel resistance":1,
"Jordan":1,
"adolescents":3,
"registry":1,
"survival":2,
"Adenocarcinoma of lung":1,
"Napsin A":1,
"Occult cancer":1,
"Ovarian clear-cell carcinoma":1,
"AREG":1,
"Cell viability":1,
"T3":1,
"miR-204":1,
"calcitonin":6,
"calcium-stimulated test":1,
"markers":1,
"Diabetes":1,
"Glucose/galactose malabsorption":1,
"Sodium glucose cotransporters":1,
"Solute carriers":1,
"Metabolism":2,
"Pyruvate kinase":1,
"Radiation therapy":2,
"Follicular variant":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"histologic subtype":1,
"parotid metastasis":1,
"bone metastasis":2,
"genetic heterogeneity":1,
"next generation sequencing":1,
"biomarker discovery":1,
"lipidomics":1,
"single nucleotide polymorphism":1,
"Disease progression":1,
"RNA-Seq":1,
"TENM1":1,
"DICER":1,
"Iodine metabolism-related genes":1,
"Thyroid cell differentiation":1,
"Thyroid tumor":3,
"Alternative chemical":1,
"Cell line":1,
"Endocrine disruption":1,
"Substitute":1,
"Disease-free survival":2,
"Family history of other cancer":1,
"Contrast-enhanced ultrasound":1,
"elastography":3,
"subcentimeter nodule":1,
"Endocrine cancers":1,
"Small RNA":1,
"Camptothecin":1,
"cell adhesion":1,
"cell migration":1,
"β-cyclodextrin-nanosponges":1,
"Galectin-3":1,
"MMP-2":1,
"MMP-9":1,
"Runx2":1,
"cancer/malignancy/neoplasia: risk factors":1,
"clinical research/practice":1,
"immunosuppression/immune modulation":1,
"kidney transplantation/nephrology":1,
"organ transplantation in general":1,
"translational research/science":1,
"transaxillary":1,
"FGFR1":1,
"PKM2":6,
"RACK1":1,
"cell growth and migration":1,
"I131":1,
"adverse events":1,
"pediatric differentiated thyroid cancer":1,
"ATP4A":1,
"Gastric neuroendocrine tumor":1,
"PTH1R":1,
"Rheumatoid arthritis":1,
"Leukocytes":2,
"platelets":1,
"white blood cells":1,
"Tg-Ab":1,
"thyroglobulin-antibodies":1,
"neck recurrence":1,
"Aggressive variant of papillary thyroid cancer":1,
"Classical papillary thyroid carcinoma":1,
"Diffuse sclerosing variant":1,
"Ongoing risk stratification":2,
"Tall cell variant":1,
"Ablación":1,
"Ablation":1,
"Cost-effectiveness":1,
"Coste-efectividad":1,
"Cáncer de tiroides":1,
"Hipotiroidismo":1,
"adult thyroid":1,
"clinical":1,
"general":1,
"radiation treatment":1,
"radiology":3,
"Cell proliferation":3,
"Follicular thyroid cancer":1,
"MAPK/Erk":1,
"PI3K/Akt":1,
"SOSTDC1":1,
"histotypes":1,
"idiopathic pulmonary fibrosis":1,
"lung carcinoma":1,
"classification":1,
"thyroid carcinoma, nonmedullary":1,
"thyroid carcinoma, papillary":1,
"novel therapies":1,
"protein kinases":1,
"protein kinases inhibitors":1,
"thyroid cancer stem cells":1,
"thyroid carcinomas":1,
"chondrosarcoma":1,
"laryngeal":1,
"medullary carcinoma":1,
"DKI":1,
"DWI":1,
"RAS mutation":1,
"adolescent":1,
"childhood":2,
"paediatric":1,
"18F-DOPA":1,
"18F-FDG":1,
"Pregnancy":3,
"cancer survivor":2,
"maternal mortality":1,
"obstetric outcome":1,
"anaplastic thyroid cancer":5,
"mammalian target of rapamycin (mTOR) inhibition":1,
"sorafenib":3,
"v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutation":1,
"TERT promoter":1,
"review":5,
"Bethesda II":1,
"False negative cytology":1,
"Malignancy":2,
"Solitary thyroid nodule":1,
"Thyroid nodule size":1,
"Hemithyroidectomy":1,
"Parathyroid gland":1,
"Cardiovascular disease":2,
"Comorbidity":1,
"Trends":1,
"cohort":1,
"neoplasm":1,
"timing":1,
"68-Ga 177-Lu DOTA &amp":1,
"PSMA":2,
"FES":1,
"PET-CT":2,
"SPECT-CT":1,
"Tumor heterogeneity":1,
"functional imaging":1,
"molecular characterization of tumor":1,
"adequacy":1,
"biopsy":2,
"multiple nodules":1,
"Hydroxylated polybrominated diphenylethers (OH-PBDEs)":1,
"Polybrominated diphenylethers (PBDEs)":1,
"Serum":1,
"Thyroid function":2,
"Convolutional neural network":1,
"Segmentation":1,
"Ultrasound image":1,
"Snx5":1,
"TSHR":1,
"endosomal trafficking":1,
"Pre-menopausal breast cancer":1,
"discrete choice experiments":1,
"endocrine therapy":1,
"long-acting formulation":1,
"practice guideline":1,
"Antiangiogenic therapy":1,
"Glioblastoma":2,
"Lenvatinib":2,
"Magnetic resonance imaging":1,
"Receptor tyrosine kinase inhibitor":1,
"goiter":1,
"neck ultrasound":1,
"thyroid gland":3,
"Cervical lymph nodes":1,
"Contrast-enhanced ultrasonography":2,
"Metastatic":2,
"Prophylactic central neck dissection":1,
"cN0":1,
"adipofascial flap":1,
"external jugular vein":1,
"veno-accompanying artery":1,
"veno-accompanying artery adipofascial (VAF)":1,
"venoadipofascial flap":1,
"National Health Insurance Research Database":2,
"radioiodine (I-131)":1,
"stroke":1,
"recurrence risk":1,
"Ablative treatment":1,
"Gamma spectrometry":1,
"Nuclear medicine":2,
"cytomorphology":1,
"fine-needle aspiration (FNA)":1,
"follicular variant of papillary thyroid carcinoma (FVPTC)":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":4,
"Fine needle aspiration and biopsy":1,
"Nodules":1,
"MAPK":3,
"PI3K":1,
"signaling":1,
"Neck mass":1,
"bone":1,
"hard":1,
"Horner's syndrome":1,
"Squamous cell carcinoma":1,
"Superior cervical ganglion":1,
"45 years":1,
"classical papillary thyroid cancer":1,
"stage I":1,
"Microwave ablation":1,
"Thermal ablation":7,
"Ultrasound-guided":1,
"MAPK pathway":1,
"Sorafenib, Forskolin":1,
"cAMP pathway":1,
"MiR-338":1,
"epigenetic modification":1,
"β-catenin":2,
"YAP1":1,
"miR-375":2,
"AUS/FLUS":1,
"FN/suspicious for FN":1,
"Lateral neck metastasis":1,
"Negative predictive value":1,
"DTC":1,
"anxiety":2,
"interview":1,
"qualitative":1,
"quality of life":1,
"Endobronchial ultrasound-guided transbronchial needle aspiration":1,
"mediastinal ectopic thyroid carcinoma":1,
"mediastinal lesion":1,
"Aspirin":1,
"Clinical research":1,
"Molecular mechanisms":1,
"Cell growth":1,
"Cell invasion":1,
"PVT1":1,
"SOX2":1,
"Transcription factor":1,
"Bisphenol A":2,
"Estrogen receptor":1,
"mTOR":1,
"Fine-needle aspiration cytology":4,
"Immunocytochemical staining":1,
"Needle wash-out fluid":1,
"chemokine":1,
"inflammation":2,
"AJCC/UICC staging system":1,
"Epidemiology and End Results":1,
"National Cancer Database":1,
"Surveillance":1,
"disease-specific survival":1,
"The Bethesda System for Reporting Thyroid Cytopathology":1,
"lncRNA":1,
"miR-129-5p":1,
"Craniopharyngioma":2,
"Diabetes insipidus":1,
"Pituitary stalk sectioning":1,
"Postoperative recovery":1,
"KLF4":1,
"cancer stem cell":1,
"chemoresistance":1,
"antineoplastic agents":1,
"lanreotide":1,
"neuroendocrine carcinoma":1,
"carcinogenesis":1,
"iodothyronine deiodinases":1,
"neoplasia":1,
"thyroid hormone receptors":1,
"mouse models":2,
"stem cells":1,
"succinate dehydrogenase":1,
"Berberine":1,
"Cell cycle arrest":1,
"Mitochondrial apoptosis":1,
"PI3K-AKT":1,
"dedifferentiation":1,
"hNIS":1,
"radioiodide resistance":1,
"tumor microenvironment":1,
"ABCG2":1,
"ALDHA1":1,
"breast cancer stem cell-like cells":1,
"doxorubicin":1,
"microbubble":1,
"RDM1":1,
"lentivirus":1,
"radioiodide sialadenitis":1,
"sialadenitis":1,
"sialendoscopy":1,
"C-cell":1,
"RET mutation":1,
"minute medullary thyroid carcinoma":1,
"solid cell nests":1,
"antiviral treatment":1,
"cardiac and pulmonary manifestations":1,
"chronic hepatitis C virus":1,
"extrahepatic manifestations":1,
"mixed cryoglobulinemia":1,
"pathogenesis":1,
"Apolipoprotein":1,
"Cholesterol efflux":1,
"Lipid":1,
"Paraoxonase-1 activity":1,
"AKT3":1,
"miR-217":1,
"Common deletion":1,
"FNA cytology":1,
"Hurthle":1,
"Infarction":1,
"Mitochondrial DNA":1,
"donors and donation":1,
"patient referral":1,
"malignancy rates":1,
"nodule":1,
"Liver transplantation":1,
"South Korea":1,
"Screening":1,
"Korea":2,
"In silico":1,
"Targets":1,
"RET M918T":1,
"cabozantinib":1,
"Childhood cancer survivor":1,
"Disfunción gonadal":1,
"Endocrine sequelae":1,
"Gonadal dysfunction":1,
"Hipopituitarismo":1,
"Hypopituitarism":1,
"Secuelas endocrinas":1,
"Superviviente cáncer infantil":1,
"Incidental cancer":1,
"Incidental thyroid nodule":1,
"mass spectrometry":1,
"proteomics":1,
"cytopathology":2,
"follicular neoplasm":3,
"terminology":2,
"Calycosin":1,
"GPR30":1,
"Long non-coding RNA":2,
"WDR7-7":1,
"end-stage renal disease":1,
"thyroid abnormalities":1,
"waiting list for renal transplant":1,
"immunotherapy":3,
"nivolumab":1,
"mean intensity ratio of intratumoral/peripheral thyroid parenchyma":1,
"microvascular density":1,
"Wnt member 5a":1,
"tumor":1,
"tyrosine kinase-like orphan receptor 2":1,
"Back pain":1,
"Dyspnoea":1,
"Error in diagnosis/pitfalls and caveats":1,
"November":1,
"Thyroid ultrasonography":1,
"Turkey":1,
"Radioiodine refractory papillary thyroid carcinoma":1,
"Thyroid stimulating hormone":2,
"Graves’ disease (GD)":1,
"Marine-Lenhart syndrome":1,
"children and adolescents":1,
"hot nodule":1,
"False-negative rate":1,
"AGREE instrument":1,
"consensus":2,
"guideline":1,
"quality of guidance document":1,
"surgical management":1,
"FYN":1,
"Receiver operating characteristic curve":1,
"Ribosomal proteins":1,
"Epigenetics":1,
"Gene mutation":1,
"Recombinant human growth hormone":1,
"Treatment outcome":1,
"Esophageal carcinoma":1,
"Gastrointestinal stromal tumors":1,
"Non-small cell lung cancer":2,
"Thyroid papillary carcinoma":1,
"multi-organ primary carcinoma":1,
"folate":1,
"folic acid":1,
"neural tube defects":1,
"safety":1,
"Thailand":1,
"The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)":1,
"Thyroid fine-needle aspiration":1,
"Autism spectrum disorder":1,
"Lung metastases":1,
"Pediatrics":1,
"antioxidant properties":1,
"nitroxide":1,
"nitroxide as drugs":1,
"oxidative stress":1,
"spin labelled drug analogues":1,
"Multinodular goitre":1,
"Saudi Arabia":1,
"Solitary nodule":1,
"Thyroid fine needle aspiration cytology":1,
"Polymorphism":1,
"Predisposition":1,
"Silicones":1,
"Surgical instruments":1,
"Surgical wound":1,
"Gamma-probe":1,
"Phytate":1,
"Sentinel lymph node biopsy":1,
"Single-photon emission-computed tomography":1,
"CD44+/CD24−":1,
"cell proliferation and chemoresistance":1,
"p63":1,
"Laser ablation":2,
"Minimally invasive therapies":1,
"Radiofrequency ablation":4,
"Positron-emission tomography":1,
"TNM staging":1,
"Ataxia-telangiectasia mutated gene-encoded protein":1,
"BCPAP cell":1,
"DNA damage response":1,
"Punicalagin":1,
"lymph node":2,
"spectral CT":1,
"anaplastic":1,
"TERT promoter mutation":1,
"GPR48/LGR4":1,
"RSPO2":1,
"β-catenin pathway":1,
"lateral":1,
"papillary":1,
"Acute paraparesis":1,
"Euthyroid sick syndrome":1,
"interleukin 6":1,
"interleukin 8":1,
"tumor necrosis factor alpha":1,
"Hodgkin's lymphoma":1,
"extra-nodal":1,
"risk factor":1,
"Cell of origin":1,
"Central nervous system prophylaxis":1,
"Diffuse large B cell lymphoma":1,
"Extranodal lymphoma":1,
"MYD88":1,
"cancer relapse":1,
"ctDNA":1,
"synchronous cancer":1,
"kidney disease":1,
"onconephrology":1,
"gestational diabetes":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"LAT1":1,
"heteromeric amino acid transporter (HAT)":1,
"inhibitor":1,
"structure":1,
"transporter":1,
"Chinese":1,
"pre-surgery":1,
"Biocontamination":1,
"Endocrine disruptors":1,
"Heavy metals":1,
"Trace elements":1,
"Volcanic environment":1,
"BDNF":1,
"in vitro cancer assay":1,
"in vivo tumorigenicity":1,
"miR-107":2,
"qRT-PCR":1,
"NSQIP":1,
"morbidity":2,
"resident":1,
"myeloid leukemias":1,
"Nuclear receptors":1,
"Pancreatic cancer":1,
"Stress/NF-kB pathway":1,
"head and neck endocrine pathology":1,
"head and neck endocrine surgery":1,
"surgical outcome":1,
"diagnostic accuracy":1,
"false positivity":1,
"intra-operative frozen section":1,
"frozen section":1,
"intra-operative":1,
"Glycoprotein":1,
"Autonomously functioning thyroid nodule":1,
"Scintigraphy":1,
"Adolescence":1,
"Follow-up studies":1,
"Thyroglossal duct&nbsp":1,
"cyst":2,
"Deiodinases":1,
"Combined small cell carcinoma":1,
"Epithelial-to-mesenchymal transition":1,
"Giant cell carcinoma":1,
"CTLA-4":1,
"Hypophysitis":1,
"Ipilimumab":1,
"acoustic rhinometer":1,
"nasal function":1,
"visual analogue scale":1,
"PTC":1,
"PTCSC3":1,
"Wnt/β-CATENIN":1,
"miR-574-5p":1,
"Endoscopic":2,
"Transoral":1,
"Transoral thyroidectomy":1,
"Focussed ultrasound":1,
"nodule shrinkage":1,
"Radiofrequency/microwave":2,
"Focused ultrasound":3,
"thyroid dysfunction":1,
"vocal cord palsy":1,
"AEROBIC GLYCOLYSIS":1,
"APOPTOSIS":2,
"COLORECTAL CANCER":3,
"GENE SILENCING":1,
"FGF2":1,
"TUMOR-ASSOCIATED MACROPHAGES":1,
"complication":1,
"Flap area":1,
"Non-unvisual dissection":1,
"Operating space":1,
"Surgery technique":1,
"Surgical time":1,
"CYP24A1":1,
"CYP27B1":1,
"Non-genomic action":1,
"Nuclear receptor":1,
"Nasopharynx":1,
"Papillary adenocarcinoma":1,
"Squamous differentiation":1,
"Squamous metaplasia":1,
"Thyroid transcription factor-1 (TTF-1)":1,
"p40 (ΔNp63)":1,
"minimally invasive treatments":1,
"percutaneous thermal ablation":1,
"Autoimmune thyroid disease":1,
"Harmonization":1,
"Immunoassay":1,
"Thyroglobulin autoantibodies":1,
"Upper reference limit":1,
"Latero-cervical lymph node metastases":1,
"Thyroid cancer metastases":1,
"Thyroid cancer outcome":1,
"acoustic radiation force impulse":1,
"sonography":1,
"strain elastography":1,
"virtual touch tissue imaging":1,
"virtual touch tissue quantification":1,
"arterial enhancement":1,
"dual-phase CT":1,
"four-dimensional computed tomography":1,
"percentage arterial enhancement":1,
"primary hyperparathyroidism":2,
"CEUS":2,
"Neuroendocrine tumors":2,
"Prediction of response":1,
"adults":1,
"individual iodine status":1,
"serum iodine":1,
"thyroid diseases":1,
"urinary iodine":1,
"incidental findings":2,
"technical report":1,
"radiofrequency":1,
"thermal ablation therapies":1,
"response to therapy":1,
"risk stratification":1,
"Non-functioning parathyroid carcinoma":1,
"RT-PCR":1,
"Immune escape":2,
"Immune microenvironment":1,
"accessory nerve injuries":1,
"head and neck neoplasms":2,
"musculoskeletal pain":1,
"neck":1,
"neuralgia":1,
"pain":1,
"upper extremity":1,
"metabolite":1,
"ACLY":1,
"Immunity":1,
"Metabolic enzymes":1,
"PDC":1,
"Retrospective study":1,
"Sensitive diagnosis":1,
"Water iodine":1,
"Antibody drug conjugated":1,
"Chemoradiotherapy":1,
"Clinical trials":1,
"Prophylactic cranial radiation":1,
"Rovalpituzumab tesirine":1,
"birth rates":1,
"marker":1,
"ethanol ablation":1,
"discordant cancer":2,
"familial cancer":2,
"familial risk":2,
"genetic association":2,
"California Cancer Registry":1,
"Middle Eastern immigrants":1,
"cancer risk":2,
"different generations":1,
"hurthle cell neoplasm":1,
"oncocytic":1,
"early diagnosis":1,
"standard population":1,
"birth outcome":1,
"Well-differentiated":1,
"18F-fluorodeoxyglucose":1,
"Multiple primary cancers":1,
"Oral cancer":1,
"Synchronous":1,
"follicular variant papillary thyroid carcinoma":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear feature":1,
"Asian Continental Ancestry Group":1,
"Filipino":1,
"Philippines":1,
"clinical decision making":1,
"health status disparities":1,
"Graves’ disease":1,
"adrenocortical carcinoma":1,
"endocrine neoplasms":1,
"immune checkpoint inhibitors":1,
"ovarian cancer":1,
"pancreatic adenocarcinoma":1,
"Aspiration cytology":1,
"Macrofollicular variant":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Body mass index":1,
"Estrogen receptors":1,
"Progesterone receptors":1,
"Waist/hip ratio":1,
"immune system":1,
"thyroid cancers":1,
"reporting system":1,
"Number of children":1,
"Parity":1,
"Thyroid cancer risk":1,
"Cervical soft tissue recurrence":1,
"GHRH antagonists":1,
"Growth hormone-releasing hormone":1,
"Hypothalamic hormone":1,
"mRNA for GHRH":1,
"mRNA for GHRH receptors":1,
"Cardiovascular diseases":1,
"Cataracts":1,
"Chernobyl":1,
"Leukemia":1,
"Multinational collaborations":1,
"Dementia":1,
"Intellectual disability":1,
"Schizophrenia":1,
"Nonmedullary thyroid carcinoma":1,
"diseases of the lacrimal system":1,
"drug-related side effects and adverse reactions":1,
"iodine radioisotopes":2,
"neoplasms of the thyroid gland/radiotherapy":1,
"radiation effects":2,
"RET oncogene":1,
"genetic variants":1,
"medullary thyroid cancer (MTC)":1,
"multiple endocrine neoplasia type 2 (MEN2)":1,
"pheochromocytoma (PHEO)":1,
"Thyroid Imaging Reporting and Data System":1,
"Medullary Thyrpod cancer":1,
"SSTR":1,
"fine needle":1,
"thyroid aspirate":1,
"COPZ1":1,
"Cell death":1,
"Non-oncogene addiction":1,
"thyrotropin":2,
"thyroxine":2,
"triiodothyronine":1,
"ANRIL":1,
"miR-199a":1,
"Irinotecan":1,
"Sunitinib":1,
"Tumor xenografts":1,
"Papillary thyroid cancer (PTC)":1,
"TRIM44":1,
"Wnt/β-catenin pathway":1,
"ligand binding assay":1,
"molecular docking":1,
"pesticides":1,
"surface plasmon resonance":1,
"thyroid receptor":1,
"Cellular biology":1,
"Molecular pathology":1,
"drug-resistance":1,
"rechallenge":1,
"tyrosine-kinase inhibitors":1,
"BABA endoscopic thyroidectomy":1,
"Bilateral axillo-breast approach":1,
"Hyperfractionated accelerated radiotherapy":1,
"Aggressive variant":1,
"Hobnail":1,
"C611Y":1,
"Cys611Tyr":1,
"Denmark":1,
"REarranged during Transfection (RET)":1,
"founder effect":1,
"multiple endocrine neoplasia 2A (MEN2A)":1,
"inter-observer variability":1,
"pathologic reporting":1,
"tall-cell variant":1,
"clinical practice":1,
"evidence-based guidelines":1,
"anatomic variant":1,
"arteria lusoria":1,
"intrathyroidal carotid artery":1,
"nonrecurring recurrent laryngeal nerve":1,
"Enigma":1,
"bone morphogenetic protein-1 (BMP-1)":1,
"American Joint Committee on Cancer":1,
"American thyroid association":1,
"gastric cancer":1,
"glucose metabolism-related enzyme":1,
"glutaminase":1,
"molecular target":1,
"pyruvate kinase isozymes M2":1,
"EGFR targeting":1,
"gene therapy":1,
"sodium–iodide symporter (NIS)":1,
"Protein kinase C δ":1,
"Ubiquitin-proteasome system":1,
"Synchronous thyroid pathology":1,
"Cellular proteins":1,
"Countermeasures":1,
"Disease impact":1,
"Graphical queries":1,
"Semantic knowledgebase":1,
"Space research":1,
"Ectopic hormone secretion":1,
"Functioning tumor":1,
"Non-functioning tumor":1,
"Pancreatic neuroendocrine neoplasm":1,
"Young adults":1,
"FOXO3a":1,
"HCC":1,
"TRIP6":1,
"cytological features":1,
"poorly differentiated thyroid carcinoma":1,
"indeterminate cytology":2,
"thyroid liquid-based fine needle aspiration":1,
"Asia":1,
"borderline tumour":1,
"resection rate":1,
"risk of malignancy":2,
"thyroid FNAC":1,
"Rb pathway":1,
"Childhood cancer":1,
"Paediatric oncology centre":1,
"Site of primary treatment":1,
"thyroid TIRADS":1,
"thyroid guidelines":1,
"Caveolin-1":1,
"PDAC":1,
"lobectomy":1,
"total thyroidectomy":1,
"Area-level Deprivation":1,
"Hazard Ratio":1,
"Survival Time":1,
"131I":1,
"outpatient":1,
"radiation safety":1,
"cancer survivors":1,
"diastolic dysfunction":1,
"late effects":1,
"pediatric patients":1,
"human bone marrow endothelial cell marker-1":1,
"ultrasonic examination":1,
"biological tumor markers":1,
"gene expression classifier":1,
"indeterminate thyroid nodules":1,
"molecular":1,
"MTOR protein, human":1,
"Neoplastic stem cells":1,
"Phosphatidylinositol 3-kinases":1,
"Thyroid carcinoma, anaplastic":1,
"Carcinome papillaire":1,
"Metastases":1,
"Métastase":1,
"Struma ovarii":1,
"Thyroïde":1,
"Curva de aprendizaje":1,
"FNAB":1,
"Learning curve":1,
"PAAF":1,
"Punción aspiración con aguja fina":1,
"Tiroides":1,
"HER2-negative breast cancer":1,
"Neoadjuvant chemotherapy":1,
"Abdominal trauma":1,
"ERCP-related perforation":1,
"Horizontal duodenal perforation":1,
"EGb":1,
"Gene expression":1,
"donor−acceptor chromophore":1,
"epidermal growth factor receptor":1,
"near-infrared window II":1,
"LC MS/MS":1,
"RIA":1,
"Thyroglobulin antibody":1,
"Microscopic extrathyroidal extension":1,
"Pathologic factor":1,
"Thyroid lobectomy":1,
"RhoA":1,
"p21cip":1,
"p27kip":1,
"simvastatin":1,
"NKX2–1":1,
"NSCLC":1,
"miR-33a":1,
"miR-365":1,
"CEA":1,
"Primary unknown origin":1,
"Soft tissue metastasis":1,
"TTF-1":2,
"glandular metastasis":1,
"kidney":1,
"Indonesia":1,
"Talaromyces marneffei":1,
"lung":1,
"talaromycosis":1,
"AMPK signaling":1,
"Anti-tumor agents":1,
"Salidroside":1,
"cyclin D1":1,
"papillary thyroid carcinoma cell":1,
"fibronectin 1":1,
"microRNA-139":1,
"progression":1,
"ERK2":1,
"Snail1":1,
"discoidin domain receptor 2":1,
"epithelial mesenchymal transition":1,
"Early detection of cancer":1,
"Second primary":1,
"Survivors":1,
"preclinical imaging":1,
"theranostic":1,
"galectins":1,
"Double water-clear cell adenoma":1,
"hypercalcemic crisis":1,
"Endoscopy":1,
"Papillary neoplasms":1,
"Glycolysis":1,
"Growth":1,
"Active surveillance":1,
"Levothyroxine-posology":1,
"Macro-thyrotropin":1,
"Polyethylene glycol-precipitable thyrotropin":1,
"Encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC)":1,
"CXC chemokine":1,
"Chemokines":1,
"Integrin alpha Ⅴ beta3":1,
"CDI/PDI":1,
"Microvascular":1,
"Microvessel density":1,
"Superb microvascular imaging":1,
"Carcinoembryonic antigen (CEA)":1,
"Fluorodeoxyglucose-positron emission tomography (FDG-PET)":1,
"NRCRM":2,
"Chornobyl":1,
"internation al cooperation":1,
"personnel":1,
"radiation hygiene":1,
"treatment of victims":1,
"Vitamin D":1,
"etiology":1,
"Endocrinology":1,
"Healthy control":1,
"Procalcitonin":1,
"Thyroid nodes":1,
"Oral vestibule":1,
"mental nerve":1,
"Cyclooxygenase-2":1,
"gene polymorphism":1,
"EGFRvIII":1,
"HNSCC":1,
"chemo-sensitivity":1,
"insulin receptor substrate 1":1,
"long noncoding RNA H19":1,
"RAS inhibitors":1,
"RET inhibitors":1,
"bioinformatics":1,
"biomarker":3,
"dysregulation network":1,
"differentially expressed mRNA":1,
"differentially expressed miRNAs":1,
"follicular thyroid tumors":1,
"gene ontology enrichment analysis":1,
"network analysis":1,
"endocrine cancer":1,
"radical resection":1,
"all-trans-retinoic acid":1,
"isotope susceptibility":1,
"sodium/iodine symporter":1,
"Deep vein thrombosis":1,
"Pulmonary embolus":1,
"PROX1":1,
"cytoskeleton":1,
"CXCL10":1,
"CXCR3":1,
"chemokine receptors":1,
"RGD peptide":1,
"TENIS syndrome":1,
"integrin αvβ3":1,
"thymus":1,
"Gas5":1,
"competing endogenous RNA":1,
"Diagnostic oncology":1,
"FNAC and histology":1,
"Clear cell oncocytoma":1,
"Parotid":1,
"STAT3":1,
"antiangiogenics":1,
"iung toxicity":1,
"radioembolization":1,
"Adenocarcinoma":1,
"Esophageal":1,
"Dermatofibrosarcoma protuberans":1,
"Hamartoma syndrome":1,
"malignant progression mRNA":1,
"miRNA":1,
"thyroid follicular adenoma":1,
"thyroid follicular carcinoma":1,
"renal transplantation":1,
"Needle Biopsy":1,
"chylous leakage":1,
"thoracoscopes":1,
"arteries":1,
"tracheotomy":1,
"veins":1,
"MIVAP":1,
"MIBI":1,
"Chemotherapy":1,
"Pemetrexed":1,
"Thyroid transcription factor-1":1,
"developmental therapeutics":1,
"tolerability study":1,
"Electron microscope":1,
"Gangliocytoma":1,
"Mixed gangliocytoma-pituitary adenoma":1,
"Sellar tumor":1,
"Surgical resection":1,
"CO2 Laser":1,
"Laryngo-Microsurgery":1,
"Larynx":1,
"Saccular Cyst":1,
"Saccule":1,
"Microvascular thyroid transplant":1,
"Radiation induced hypothyroidism":1,
"DPF3":1,
"SWI/SNF complex":1,
"MiR-381":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年第4季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
